# Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis

> **NCT07088042** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **DRUG:** Limitless Allzyme
- **DRUG:** Oral tablets of Alphintern®
- **DRUG:** Cataflam® 50 coated tablet

## Key facts

- **NCT ID:** NCT07088042
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-15
- **Primary completion:** 2025-02-17
- **Final completion:** 2025-02-17
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07088042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07088042, "Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07088042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*